Search

Your search keyword '"Maryam Kavousi"' showing total 434 results

Search Constraints

Start Over You searched for: Author "Maryam Kavousi" Remove constraint Author: "Maryam Kavousi"
434 results on '"Maryam Kavousi"'

Search Results

151. Sex steroids and markers of micro- and macrovascular damage among women and men from the general population

152. Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis

153. Association between arterial stiffness/remodeling and new-onset type 2 diabetes mellitus in general population

154. Atherosclerotic calcification in major vessel beds in chronic obstructive pulmonary disease: The Rotterdam Study

155. Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study

157. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

158. Longitudinal Anthropometric Measures and Risk of New-Onset Atrial Fibrillation Among Community-Dwelling Men and Women

159. Obesity Partially Mediates the Diabetogenic Effect of Lowering LDL Cholesterol

160. Longitudinal changes of thoracic aortic diameters in the general population aged 55 years or older

161. Genetic analyses of the QT interval and its components in over 250K individuals identifies new loci and pathways affecting ventricular depolarization and repolarization

162. Arterial calcification at different sites and prediction of atherosclerotic cardiovascular disease among women and men

163. Heart rate variability and incident type 2 diabetes mellitus

164. Lipoprotein(a) is associated with incidence but not progression of aortic valve calcium

165. Distribution and risk profile of atrial fibrillation patterns among women and men from the general population

166. Immunothrombosis and new-onset atrial fibrillation in the general population

167. Trajectories of metabolic risk factors and risk of new-onset atrial fibrillation among men and women

168. Sex-specific normal values and determinants of infrarenal abdominal aortic diameter among non-aneurysmal elderly population

169. The genomics of heart failure: design and rationale of the HERMES consortium

170. Epicardial fat volume and the risk of cardiometabolic diseases among women and men from the general population

171. Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: Has there been progress?

172. Multiethnic Genome-Wide Association Study of Subclinical Atherosclerosis in Individuals With Type 2 Diabetes

173. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies

174. Genetic susceptibility, obesity and lifetime risk of type 2 diabetes

175. Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study

176. Chronic obstructive pulmonary disease and the development of atrial fibrillation

177. Association of migraine with calcification in major vessel beds: The Rotterdam Study

178. Thyroid Function and Cardiovascular Disease: The Mediating Role of Coagulation Factors

179. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study

182. Cardiovascular health, genetic predisposition, and lifetime risk of type 2 diabetes

183. MiR-139-5p is a causal biomarker for type 2 diabetes; Results from genome-wide microRNA profiling and Mendelian randomization analysis in a population-based study

184. Association between circulatory microRNAs in plasma and atrial fibrillation among men and women from the general population

185. Cardiac biomarkers for cardiovascular risk prediction among women and men from the general population

186. Associations of markers of arterial stiffness and remodeling with new-onset type 2 diabetes mellitus

188. Long-term association of pregnancy and maternal brain structure: the Rotterdam Study

189. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin

190. Association of circulating monocyte chemoattractant protein-1 levels with cardiovascular mortality: A meta-analysis of population-based studies

191. Associations between macronutrient intake and coronary heart disease (CHD): The Rotterdam Study

193. Heart failure and promotion of physical activity before and after cardiac rehabilitation (HF-aPProACH)

194. Aging, Cardiovascular Risk, and SHBG Levels in Men and Women from the General Population

195. Arterial calcification at different sites and prediction of atherosclerotic cardiovascular disease among women and men

196. Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men

197. Sex-specific normal values and determinants of infrarenal abdominal aortic diameter among non-aneurysmal elderly population

198. Genetic susceptibility, obesity and lifetime risk of type 2 diabetes

199. Circulatory markers of immunity and carotid atherosclerotic plaque

200. Author response: Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

Catalog

Books, media, physical & digital resources